Evidence
Harv Rev Psychiatry. 2024 Jan-Feb 01;32(1):40-46. doi: 10.1097/HRP.0000000000000387.
ABSTRACT
Anecdotal evidence of superior efficacy and lack of extrapyramidal symptoms in treating schizophrenia made clozapine a promising therapy in the United States during the early 1970s. In 1975, however, numerous fatal cases of clozapine-related agranulocytosis in Finland nearly ended the drug’s development. Convinced of the significant benefits to patients, some clinicians in the United States advocated having clozapine available on a case-by-case humanitarian basis, which eventually helped resurrect the drug for Food and Drug Administration approval in 1989. This article builds on previous literature by utilizing oral histories from clinicians, researchers, and a patient’s family member to understand how clozapine was saved. Exploring these stakeholders’ perspectives has value to modern clinicians, who underprescribe the drug despite demonstrable benefits for treatment-resistant schizophrenia and suicide prevention.
PMID:38181102 | DOI:10.1097/HRP.0000000000000387
Add to Google Keep
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D
Cool Evidence: Engaging Young People and Students in Real-World Evidence ☀️
Real-Time Evidence Search [Psychiatry]
AI Research [Andisearch.com]
The Tarnished Legacy of a Wonder Drug: Revisiting the Complicated History of Clozapine
🌐 90 Days
VR Related Evidence Matrix
- Long-term persistence of the risk of agranulocytosis with clozapine compared with other antipsychotics: a nationwide cohort and case-control study in Finland
- Long-term persistence of the risk of agranulocytosis with clozapine compared with other antipsychotics: a nationwide cohort and case-control study in Finland
- Optimizing co-prescription of clozapine and antiseizure medications: a systematic review and expert recommendations for clinical practice
- Successful Clozapine Rechallenge After Clozapine-Induced Severe Anemia: A Case Report
- Clozapine Efficacy and Adverse Drug Reactions Among a Nationwide Study of 1021 Australians Prescribed Clozapine: The ClozaGene Study
- Clozapine Efficacy and Adverse Drug Reactions Among a Nationwide Study of 1021 Australians Prescribed Clozapine: The ClozaGene Study
- Overcoming the barriers to identifying and managing treatment-resistant schizophrenia and to improving access to clozapine: A narrative review and recommendation for clinical practice
- Dual Atypical Antipsychotics in Treatment-Resistant Schizophrenia: A Correctional Case Report and Review of Literature
- Clozapine-laden carbon dots delivered to the brain via an intranasal pathway: Synthesis, characterization, ex vivo, and in vivo studies
- Remission of Clozapine-Induced Hepatotoxicity Following a Switch to Olanzapine Augmented with Haloperidol: A Case Report and Literature Review
- Neuroreceptor Inhibition by Clozapine Triggers Mitohormesis and Metabolic Reprogramming in Human Blood Cells
- Association Between Clozapine Exposure and Risk of Hematologic Malignancies in Veterans With Schizophrenia
- Clearing the Fog: A Review of Antipsychotics for Parkinson's-Related Hallucinations: A Focus on Pimavanserin, Quetiapine and Clozapine
- Antipsychotic-Related DRESS Syndrome: Analysis of Individual Case Safety Reports of the WHO Pharmacovigilance Database
- Relationship Between Clozapine and Non-Hematological Malignant Tumors: A Pharmacovigilance Analysis Using the FDA Adverse Event Reporting System Database
- A Case Report of a Patient with Soaring Clozapine Levels after Developing a Urinary Tract Infection
- Identifying and managing treatment resistance early with the integration of a clozapine clinic within an early intervention for psychosis service
- Comparative Study of the Efficacy and Side Effects of Brand-Name and Generic Clozapine for Long-Term Maintenance Treatment Among Korean Patients With Schizophrenia: A Retrospective Naturalistic Mirror-Image Study
- Chromatographic Methods for the Analysis of the Antipsychotic Drug Clozapine and Its Major Metabolites: A Review
- Knee Buckling as an Atypical Adverse Effect of Clozapine: A Case Report
- Exploring clozapine use in severe psychiatric symptoms associated with autism spectrum disorder: A scoping review
- Effect of propranolol on pharmacokinetics of clozapine in schizophrenic patients: a meta-analysis
- Rapid Metabolism Underlying Subtherapeutic Serum Levels of Atypical Antipsychotics Preceding Clozapine Treatment: A Retrospective Analysis of Real-World Data
- Clozapine Use Among People With Psychotic Disorders Who Experience Specific Indications for Clozapine
- Clozapine Use Among People With Psychotic Disorders Who Experience Specific Indications for Clozapine
- The role of psychosis and clozapine load in excessive checking in treatment-resistant schizophrenia: longitudinal observational study
- The role of psychosis and clozapine load in excessive checking in treatment-resistant schizophrenia: longitudinal observational study
- Identification and treatment of individuals with childhood-onset and early-onset schizophrenia
- Identification and treatment of individuals with childhood-onset and early-onset schizophrenia
- Endocannabinoid system alterations in schizophrenia: association with cannabis use and antipsychotic medication
- Bridging the Divide: An Integrated Neurobio-Psycho-Social Approach to Treating Antibody Negative Inflammatory Encephalitis in a School-Aged Child
- Blood Cell Count Ratios at Baseline are Associated with Initial Clinical Response to Clozapine in Treatment-Resistant, Clozapine-Naïve, Schizophrenia-Spectrum Disorder
- Polymorphisms in ERBB4 and TACR1 associated with dry mouth in clozapine-treated patients
- Second-generation antipsychotics for Parkinson's disease psychosis: A systematic review and network meta-analysis
- Impact of patient-specific factors on clozapine metabolism in individuals with treatment-resistant schizophrenia or schizoaffective disorder
- Clozapine Prescripers-Dogmatic or Pragmatic?
- Zolpidem Stimulant Effect and Dependence: A Case Report on Intranasal Use
- Zolpidem Stimulant Effect and Dependence: A Case Report on Intranasal Use
- Zolpidem Stimulant Effect and Dependence: A Case Report on Intranasal Use
- Broad evidence of xylazine in the UK illicit drug market beyond heroin supplies: Triangulating from toxicology, drug-testing and law enforcement
- Increases in drug-related infant mortality in the United States
- The Role of Psychiatry for Transgender and Gender Diverse Adults
- The Role of Psychiatry for Transgender and Gender Diverse Adults
- Risperidone-Induced Leukoneutropenia: Evidence from a Positive Rechallenge and Review of the Literature
- Psychedelic Therapy: A Primer for Primary Care Clinicians-3,4-Methylenedioxy-methamphetamine (MDMA)
- Antipsychotic Use and Psychiatric Hospitalization in First-Episode Non-affective Psychosis and Cannabis Use Disorder: A Swedish Nationwide Cohort Study
- Pediatric Extrapolation Approach for U.S. Food and Drug Administration Approval of Brexpiprazole in Patients Aged 13 to 17 Years with Schizophrenia
- Drugs, guns, and violent crime in California
- CD73 polymorphisms are associated with schizophrenia
- The Role of AI in Drug Discovery
- Neurosurgical neuromodulation therapy for psychiatric disorders
- Methadone Withdrawal-Induced Psychosis: A Case Report
- Case report: Avoiding intolerance to antipsychotics through a personalized treatment approach based on pharmacogenetics
- Posterior reversible encephalopathy syndrome associated with antibiotic therapy: a case report and systematic review
- Elevated intrinsic cortical curvature in treatment-resistant schizophrenia: Evidence of structural deformation in functional connectivity areas and comparison with alternate indices of structure
- Proof-of-concept evidence for high-density EEG investigation of sleep slow wave traveling in First-Episode Psychosis
- Regional differences in fatal drug overdose deaths among Black and White individuals in the United States, 2012-2021
- Clozapine Treatment for Aggressive Behaviors in Youths with Neurodevelopmental Disorders
- Rivastigmine: Dementia with Lewy Bodies
- Evaluating the accuracy of Chat Generative Pre-trained Transformer version 4 (ChatGPT-4) responses to United States Food and Drug Administration (FDA) frequently asked questions about dental amalgam
- Antipsychotic drugs selectively decorrelate long-range interactions in deep cortical layers
- Multiscale topology in interactomic network: from transcriptome to antiaddiction drug repurposing
- Neuralink and Brain-Computer Interface-Exciting Times for Artificial Intelligence
- Right-sided vagus nerve stimulation for drug-resistant epilepsy: A systematic review of the literature and perspectives
Evidence Blueprint
The Tarnished Legacy of a Wonder Drug: Revisiting the Complicated History of Clozapine
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
The Tarnished Legacy of a Wonder Drug: Revisiting the Complicated History of Clozapine
🌐 365 Days
VR Related Evidence Matrix
- Rethinking Clozapine: Lights and Shadows of a Revolutionary Drug
- A scoping review of literature on clozapine from former USSR states published in Russian language
- Long-term persistence of the risk of agranulocytosis with clozapine compared with other antipsychotics: a nationwide cohort and case-control study in Finland
- Long-term persistence of the risk of agranulocytosis with clozapine compared with other antipsychotics: a nationwide cohort and case-control study in Finland
- Clozapine-Associated Agranulocytosis: A Systematic Review. Is It Really So Frighteningly Common?
- Optimizing co-prescription of clozapine and antiseizure medications: a systematic review and expert recommendations for clinical practice
- Successful Clozapine Rechallenge After Clozapine-Induced Severe Anemia: A Case Report
- Significant improvement of psychotic symptoms in treatment-resistant schizophrenia with clozapine in an adolescent with SHINE syndrome: a case report
- Clozapine-induced eosinophilia: A case report
- Non-Psychosis Symptoms of Clozapine Withdrawal: a Systematic Review
- Clozapine Efficacy and Adverse Drug Reactions Among a Nationwide Study of 1021 Australians Prescribed Clozapine: The ClozaGene Study
- Clozapine Efficacy and Adverse Drug Reactions Among a Nationwide Study of 1021 Australians Prescribed Clozapine: The ClozaGene Study
- Overcoming the barriers to identifying and managing treatment-resistant schizophrenia and to improving access to clozapine: A narrative review and recommendation for clinical practice
- Revealing the reporting disparity: VigiBase highlights underreporting of clozapine in other Western European countries compared to the UK
- Comprehensive dissection of prevalence rates, sex differences, and blood level-dependencies of clozapine-associated adverse drug reactions
- Inflammatory markers in outpatients with schizophrenia diagnosis in regular use of clozapine: a cross-sectional study
- Virtual twins for model-informed precision dosing of clozapine in patients with treatment-resistant schizophrenia
- Dual Atypical Antipsychotics in Treatment-Resistant Schizophrenia: A Correctional Case Report and Review of Literature
- Vaccination and clozapine use: a systematic review and an analysis of the VAERS database
- Potential impact on mental health in patients with treatment-resistant schizophrenia - clozapine augmentation with long-acting parenteral antipsychotics: a case series
- Potential impact on mental health in patients with treatment-resistant schizophrenia - clozapine augmentation with long-acting parenteral antipsychotics: a case series
- Utilizing plasma drug levels and genetic testing to achieve optimal treatment response in a patient with treatment-resistant schizoaffective disorder
- Change in absolute neutrophil count after COVID-19 infection in patients using clozapine versus other antipsychotics
- Therapeutic Drug Level Monitoring of Antipsychotics at an Inpatient Psychiatric Hospital
- Clozapine-laden carbon dots delivered to the brain via an intranasal pathway: Synthesis, characterization, ex vivo, and in vivo studies
- A brief history of clozapine use in Taiwan
- A systematic review of clozapine for aggression and violence in patients with schizophrenia or schizoaffective disorder
- Clozapine-induced myocarditis and subsequent rechallenge: a narrative literature review and case report
- Overcoming Obstacles to Clozapine Treatment: A Case of Clozapine Rechallenge in ECT-Resistant Schizophrenia With Catatonic Features
- Current practice for clozapine-induced leukopenia in Japanese psychiatric hospitals: A nationwide survey
- Clozapine Withdrawal Catatonia: A Case Report
- Remission of Clozapine-Induced Hepatotoxicity Following a Switch to Olanzapine Augmented with Haloperidol: A Case Report and Literature Review
- Neuroreceptor Inhibition by Clozapine Triggers Mitohormesis and Metabolic Reprogramming in Human Blood Cells
- Clozapine Serum Concentrations Are Disrupted by SARS-CoV-2 Vaccinations
- An international research agenda for clozapine-resistant schizophrenia
- Association Between Clozapine Exposure and Risk of Hematologic Malignancies in Veterans With Schizophrenia
- Patient safety: adverse effects of Clozapine and their management at the Psychiatric Hospital Ghrasia in Yogyakarta, Indonesia
- Clearing the Fog: A Review of Antipsychotics for Parkinson's-Related Hallucinations: A Focus on Pimavanserin, Quetiapine and Clozapine
- Safety aspects during treatment with clozapine. : Monitoring and rechallenge - a narrative review
- Real-World Effectiveness of High-Dose Olanzapine and Clozapine for Treatment-Resistant Schizophrenia in Japan: A Retrospective Bidirectional Mirror-Image Study
- Schizophrenia patients discharged on clozapine plus long-acting injectable antipsychotics from a public psychiatric hospital in Taiwan, 2006-2021
- Antipsychotic-Related DRESS Syndrome: Analysis of Individual Case Safety Reports of the WHO Pharmacovigilance Database
- Relationship Between Clozapine and Non-Hematological Malignant Tumors: A Pharmacovigilance Analysis Using the FDA Adverse Event Reporting System Database
- A Case Report of a Patient with Soaring Clozapine Levels after Developing a Urinary Tract Infection
- Identifying and managing treatment resistance early with the integration of a clozapine clinic within an early intervention for psychosis service
- The lived experience of clozapine discontinuation in patients and carers following suspected clozapine-induced neutropenia
- Comparative Study of the Efficacy and Side Effects of Brand-Name and Generic Clozapine for Long-Term Maintenance Treatment Among Korean Patients With Schizophrenia: A Retrospective Naturalistic Mirror-Image Study
- Higher orexin-A levels are associated with treatment response to clozapine in patients with schizophrenia: A cross-sectional study
- Early neutrophil trajectory following clozapine may predict clozapine response - Results from an observational study using electronic health records
- Chromatographic Methods for the Analysis of the Antipsychotic Drug Clozapine and Its Major Metabolites: A Review
- Clozapine augmentation with long-acting antipsychotic injections: A case series and systematic review
- Obsessive-Compulsive Symptoms and Disorder in Clozapine-treated Schizophrenia
- Knee Buckling as an Atypical Adverse Effect of Clozapine: A Case Report
- Exploring clozapine use in severe psychiatric symptoms associated with autism spectrum disorder: A scoping review
- Clozapine for the treatment of aggressiveness and agitation in advanced dementia
- Effect of propranolol on pharmacokinetics of clozapine in schizophrenic patients: a meta-analysis
- Rapid Metabolism Underlying Subtherapeutic Serum Levels of Atypical Antipsychotics Preceding Clozapine Treatment: A Retrospective Analysis of Real-World Data
- Clozapine for treatment refractory catatonia in individuals with autism spectrum disorder: a retrospective chart review study
- Rhabdomyolysis during adjunctive treatment with cariprazine in a clozapine-resistant schizophrenia patient
- Clozapine Use Among People With Psychotic Disorders Who Experience Specific Indications for Clozapine
- Clozapine Use Among People With Psychotic Disorders Who Experience Specific Indications for Clozapine
- Long-term outcomes of delayed clozapine initiation in treatment-resistant schizophrenia: a multicenter retrospective cohort study
- The Impact of Clozapine Delay on Clinical Outcomes in Schizophrenia
- Relationship between C-reactive protein and antipsychotics levels in schizophrenic patients infected with COVID-19